Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare, hormonally functioning or non-functioning pituitary gland adenocarcinoma that produces thyrotropin.
No clinical trials have been registered for malignant thyroid stimulating hormone producing neoplasm of pituitary gland.
5 publications have been identified in PubMed for malignant thyroid stimulating hormone producing neoplasm of pituitary gland. Research spans Case Report / Case Series (40%), Basic Science / Preclinical (40%), and Review / Meta-Analysis (20%).
Kasuga E (2025). [PMID: 40468622](https://pubmed.ncbi.nlm.nih.gov/40468622/). *Clinical endocrinology*. [Basic Science / Preclinical]
Yano J (2025). [PMID: 40315979](https://pubmed.ncbi.nlm.nih.gov/40315979/). *Regulatory toxicology and pharmacology : RTP*. [Basic Science / Preclinical]
Peng S (2025). [PMID: 40496040](https://pubmed.ncbi.nlm.nih.gov/40496040/). *Molecular and clinical oncology*. [Case Report / Case Series]
Kostyleva DN (2024). [PMID: 39302862](https://pubmed.ncbi.nlm.nih.gov/39302862/). *Problemy endokrinologii*. [Case Report / Case Series]
Shimon I (2024). [PMID: 39356415](https://pubmed.ncbi.nlm.nih.gov/39356415/). *Reviews in endocrine & metabolic disorders*. [Review / Meta-Analysis]
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 2:42 AM UTC